Boxer Capital, LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2021$19,672,000
-10.2%
1,050,2890.0%0.69%
-11.1%
Q2 2021$21,899,000
-26.2%
1,050,2890.0%0.77%
-23.2%
Q1 2021$29,692,000
-13.4%
1,050,2890.0%1.01%
-8.7%
Q4 2020$34,302,000
+6.6%
1,050,2890.0%1.10%
-0.8%
Q3 2020$32,181,000
+133.7%
1,050,289
+24.3%
1.11%
+83.8%
Q2 2020$13,770,000
+63.8%
844,7890.0%0.60%
+5.6%
Q1 2020$8,406,000
-27.6%
844,7890.0%0.57%
-12.8%
Q4 2019$11,616,000
-9.4%
844,7890.0%0.66%
-29.3%
Q3 2019$12,815,000
-23.0%
844,7890.0%0.93%
-35.0%
Q2 2019$16,634,000
+18.7%
844,7890.0%1.43%
-11.8%
Q1 2019$14,015,000
+18.2%
844,7890.0%1.62%
+10.6%
Q4 2018$11,861,000
-19.8%
844,7890.0%1.46%
-10.7%
Q3 2018$14,784,000
-3.8%
844,7890.0%1.64%
-5.8%
Q2 2018$15,375,000
-2.9%
844,7890.0%1.74%
+3.0%
Q1 2018$15,840,000
+22.6%
844,7890.0%1.69%
-28.4%
Q4 2017$12,925,000
+2.3%
844,7890.0%2.36%
-17.8%
Q3 2017$12,630,000
+154.7%
844,789
+58.4%
2.88%
+143.9%
Q2 2017$4,959,000
+5.7%
533,2510.0%1.18%
+15.0%
Q1 2017$4,693,000
+49.2%
533,2510.0%1.02%
-15.8%
Q4 2016$3,146,000
-5.6%
533,2510.0%1.22%
-18.5%
Q3 2016$3,333,000
+94.1%
533,251
-15.9%
1.49%
-1.8%
Q2 2016$1,717,000
-34.3%
633,692
-1.9%
1.52%
-40.5%
Q1 2016$2,615,000
-52.4%
645,685
-1.4%
2.56%
-46.1%
Q4 2015$5,499,000654,5954.75%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders